• 13065 Citations
  • 38 h-Index
1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Daniel D Karp is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Phase 2 study of pembrolizumab in patients with advanced rare cancers

Naing, A., Meric-Bernstam, F., Stephen, B., Karp, D. D., Hajjar, J., Rodon Ahnert, J., Piha-Paul, S. A., Colen, R. R., Jimenez, C., Raghav, K. P., Ferrarotto, R., Tu, S. M., Campbell, M., Wang, L., Sabir, S. H., Tapia, C., Bernatchez, C., Frumovitz, M., Tannir, N., Ravi, V. & 20 others, Khan, S., Painter, J. M., Abonofal, A., Gong, J., Alshawa, A., McQuinn, L. M., Xu, M., Ahmed, S., Subbiah, V., Hong, D. S., Pant, S., Yap, T. A., Tsimberidou, A. M., Dumbrava, E. E. I., Janku, F., Fu, S., Simon, R. M., Hess, K. R., Varadhachary, G. R. & Amir Habra, M., Mar 1 2020, In : Journal for immunotherapy of cancer. 8, 1

Research output: Contribution to journalArticle

Open Access
  • 2 Scopus citations

    Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract

    Frumovitz, M., Westin, S. N., Salvo, G., Zarifa, A., Xu, M., Yap, T. A., Rodon, A. J., Karp, D. D., Abonofal, A., Jazaeri, A. A. & Naing, A., Jan 1 2020, (Accepted/In press) In : Gynecologic oncology.

    Research output: Contribution to journalArticle

  • Open Access
  • Open Access
  • 2 Scopus citations
    Open Access